|
1
|
Siegel RL, Wagle NS, Cercek A, Smith RA
and Jemal A: Colorectal cancer statistics, 2023. CA Cancer J Clin.
73:233–254. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Levin TR, Corley DA, Jensen CD,
Schottinger JE, Quinn VP, Zauber AG, Lee JK, Zhao WK, Udaltsova N,
Ghai NR, et al: Effects of organized colorectal cancer screening on
cancer incidence and mortality in a large community-based
population. Gastroenterology. 155:1383–1391.e5. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wolf AMD, Fontham ETH, Church TR, Flowers
CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC,
Shih YT, et al: Colorectal cancer screening for average-risk
adults: 2018 guideline update from the american cancer society. CA
Cancer J Clin. 68:250–281. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shaukat A and Levin TR: Current and future
colorectal cancer screening strategies. Nat Rev Gastroenterol
Hepatol. 19:521–531. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ding H, Lin J, Xu Z, Chen X, Wang HHX,
Huang L, Huang J, Zheng Z and Wong MCS: A global evaluation of the
performance indicators of colorectal cancer screening with fecal
immunochemical tests and colonoscopy: A systematic review and
meta-analysis. Cancers (Basel). 14(1073)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li L, Gu W, Wu X, Ao Y, Song Y, Li X and
Zeng Q: Superiority of fecal carcinoembryonic antigen as diagnosis
marker for adenomatous polyposis coli and asymptomatic colorectal
cancer. Ther Adv Gastroenterol.
14(17562848211062792)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mojtabanezhad Shariatpanahi A, Yassi M,
Nouraie M, Sahebkar A, Varshoee Tabrizi F and Kerachian MA: The
importance of stool DNA methylation in colorectal cancer diagnosis:
A meta-analysis. PLoS One. 13(e0200735)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tinmouth J, Lansdorp-Vogelaar I and
Allison JE: Faecal immunochemical tests versus guaiac faecal occult
blood tests: What clinicians and colorectal cancer screening
programme organisers need to know. Gut. 64:1327–1337.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Castanon A, Parmar D, Massat NJ, Sasieni P
and Duffy SW: Benefit of biennial fecal occult blood screening on
colorectal cancer in England: A population-based case-control
study. J Natl Cancer Inst. 114:1262–1269. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hewitson P, Glasziou P, Watson E, Towler B
and Irwig L: Cochrane systematic review of colorectal cancer
screening using the fecal occult blood test (hemoccult): An update.
Am J Gastroenterol. 103:1541–1549. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Alampritis G, Thoukididou SN, Ramos M,
Georgiou P, Kalofonou M and Simillis C: Diagnostic value of genetic
and epigenetic biomarker panels for colorectal cancer detection: A
systematic review. Int J Colorectal Dis. 40(125)2025.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Carroll MRR, Seaman HE and Halloran SP:
Tests and investigations for colorectal cancer screening. Clin
Biochem. 47:921–939. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Imperiale TF, Gruber RN, Stump TE, Emmett
TW and Monahan PO: Performance characteristics of fecal
immunochemical tests for colorectal cancer and advanced adenomatous
polyps: A systematic review and meta-analysis. Ann Intern Med.
170:319–329. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Chen H, Shi J, Lu M, Li Y, Du L, Liao X,
Wei D, Dong D, Gao Y, Zhu C, et al: Comparison of colonoscopy,
fecal immunochemical test, and risk-adapted approach in a
colorectal cancer screening trial (TARGET-C). Clin Gastroenterol
Hepatol. 21:808–818. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Senore C, Basu P, Anttila A, Ponti A,
Tomatis M, Vale DB, Ronco G, Soerjomataram I, Primic-Žakelj M,
Riggi E, et al: Performance of colorectal cancer screening in the
European union member states: Data from the second European
screening report. Gut. 68:1232–1244. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ren Y, Zhao M, Zhou D, Xing Q, Gong F and
Tang W: Cost-effectiveness analysis of colonoscopy and fecal
immunochemical testing for colorectal cancer screening in China.
Front Public Health. 10(952378)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhong GC, Sun WP, Wan L, Hu JJ and Hao FB:
Efficacy and cost-effectiveness of fecal immunochemical test versus
colonoscopy in colorectal cancer screening: A systematic review and
meta-analysis. Gastrointest Endosc. 91:684–697.e15. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Grobbee EJ, Van Der Vlugt M, Van Vuuren
AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt
PMM, Kuipers EJ, Dekker E and Spaander MCW: Diagnostic yield of
one-time colonoscopy vs one-time flexible sigmoidoscopy vs multiple
rounds of mailed fecal immunohistochemical tests in colorectal
cancer screening. Clin Gastroenterol Hepatol. 18:667–675.e1.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gao Y, Wang J, Zhou Y, Sheng S, Qian SY
and Huo X: Evaluation of serum CEA, CA19-9, CA72-4, CA125 and
ferritin as diagnostic markers and factors of clinical parameters
for colorectal cancer. Sci Rep. 8(2732)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
You W, Sheng N, Yan L, Chen H, Gong J, He
Z, Zheng K, Chen Z, Wang Y, Tan G, et al: The difference in
prognosis of stage II and III colorectal cancer based on
preoperative serum tumor markers. J Cancer. 10:3757–3766.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kildusiene I, Dulskas A and Smailyte G:
Value of combined serum CEA, CA72-4, and CA19-9 marker detection in
diagnosis of colorectal cancer. Tech Coloproctol.
28(33)2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang ZY, Li KJ, Zeng XY, Wang K, Sulayman
S, Chen Y and Zhao ZL: Early prediction of anastomotic leakage
after rectal cancer surgery: Onodera prognostic nutritional index
combined with inflammation-related biomarkers. World J Gastrointest
Surg. 17(102862)2025.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang Y, Xu J, Qian J, Qiu J, Zhu M and
Wang D: Retrospective analysis of risk factors and prediction model
of cervical anastomotic and intrathoracic anastomotic leakage after
radical esophagectomy. Cancer Rep (Hoboken).
8(e70286)2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shayimu P, Awula M, Wang CY, Jiapaer R,
Pan YP, Wu ZM, Chen Y and Zhao ZL: Serum nutritional predictive
biomarkers and risk assessment for anastomotic leakage after
laparoscopic surgery in rectal cancer patients. World J
Gastrointest Surg. 16:3142–3154. 2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang K, Li K, Zhang Z, Zeng X, Wu Z, Zhang
B, Pan Y, Lau LY, Zhao Z and Chen Y: Combined preoperative
platelet-albumin ratio and cancer inflammation prognostic index
predicts prognosis in colorectal cancer: A retrospective study. Sci
Rep. 15(29500)2025.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chini A, Manigrasso M, Cantore G, Maione
R, Milone M, Maione F and De Palma GD: Can computed tomography
colonography replace optical colonoscopy in detecting colorectal
lesions?: State of the art. Clin Endosc. 55:183–190.
2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Grosu S, Fabritius MP, Winkelmann M,
Puhr-Westerheide D, Ingenerf M, Maurus S, Graser A, Schulz C,
Knösel T, Cyran CC, et al: Effect of artificial intelligence-aided
differentiation of adenomatous and non-adenomatous colorectal
polyps at CT colonography on radiologists' therapy management. Eur
Radio. 35:4091–4099. 2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Spada C, Hassan C, Bellini D, Burling D,
Cappello G, Carretero C, Dekker E, Eliakim R, de Haan M, Kaminski
MF, et al: Imaging alternatives to colonoscopy: CT colonography and
colon capsule. European society of gastrointestinal endoscopy
(ESGE) and european society of gastrointestinal and abdominal
radiology (ESGAR) guideline-update 2020. Endoscopy. 52:1127–1141.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Rajendiran A, Neupane P, Zapadia V, Biswas
S, Kyriakides R, Butt MH, Simpson M and Hussain A: Diagnostic yield
of combining CT colonoscopy and endoscopy to investigate colorectal
cancer. J Gastrointest Cancer. 56(93)2025.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Millerd PJ, Paden RG, Lund JT, Hara AK,
Stiles WL, He M, Wu Q and Johnson CD: Reducing the radiation dose
for computed tomography colonography using model-based iterative
reconstruction. Abdom Imaging. 40:1183–1189. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Katabathina VS, Menias CO, Khanna L,
Murphy L, Dasyam AK, Lubner MG and Prasad SR: Hereditary
gastrointestinal cancer syndromes: Role of imaging in screening,
diagnosis, and management. Radiographics. 39:1280–1301.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
US Preventive Services Task Force.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM,
Donahue KE, Doubeni CA, Krist AH, et al: Screening for colorectal
cancer: US preventive services task force recommendation statement.
JAMA. 325:1965–1977. 2021.
|
|
33
|
Castagnoli F: CT colonography for
colorectal cancer screening: Challenges and opportunities for
clinical integration. AJR Am J Roentgenol: Mar 26, 2025 (Epub ahead
of print).
|
|
34
|
Pickhardt PJ, Correale L and Hassan C: CT
colonography versus multitarget stool DNA test for colorectal
cancer screening: A cost-effectiveness analysis. Radiology.
315(e243775)2025.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Van Der Meulen MP, Lansdorp-Vogelaar I,
Goede SL, Kuipers EJ, Dekker E, Stoker J and Van Ballegooijen M:
Colorectal cancer: Cost-effectiveness of colonoscopy versus CT
colonography screening with participation rates and costs.
Radiology. 287:901–911. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Pan H, Zheng XL, Fang CY, Liu LZ, Chen JS,
Wang C, Chen YD, Huang JM, Zhou YS and He LP: Same-day single-dose
vs large-volume split-dose regimens of polyethylene glycol for
bowel preparation: A systematic review and meta-analysis. World J
Clin Cases. 10:7844–7858. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kim H, Melio A, Simianu V and Mankaney G:
Challenges and opportunities for colorectal cancer prevention in
young patients. Cancers (Basel). 17(2043)2025.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mansur A, Garg T, Shrigiriwar A, Etezadi
V, Georgiades C, Habibollahi P, Huber TC, Camacho JC, Nour SG, Sag
AA, et al: Image-guided percutaneous ablation for primary and
metastatic tumors. Diagnostics (Basel). 12(1300)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu W, Zeng AR, Tang HZ and Qiang JW:
Radiologic imaging modalities for colorectal cancer. Dig Dis Sci.
67:2792–2804. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jayasinghe M, Prathiraja O, Caldera D,
Jena R, Coffie-Pierre JA, Silva MS and Siddiqui OS: Colon cancer
screening methods: 2023 update. Cureus. 15(e37509)2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gao Y, Wang J, Lv H, Xue Y, Jia R, Liu G,
Bai W, Wu Y, Zhang L and Yang J: Diagnostic value of magnetic
resonance and computed tomography colonography for the diagnosis of
colorectal cancer: A systematic review and meta-analysis. Medicine
(Baltimore). 98(e17187)2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Eliakim R, Fireman Z, Gralnek IM, Yassin
K, Waterman M, Kopelman Y, Lachter J, Koslowsky B and Adler SN:
Evaluation of the PillCam colon capsule in the detection of colonic
pathology: Results of the first multicenter, prospective,
comparative study. Endoscopy. 38:963–970. 2006.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Van Gossum A, Munoz-Navas M,
Fernandez-Urien I, Carretero C, Gay G, Delvaux M, Lapalus MG,
Ponchon T, Neuhaus H, Philipper M, et al: Capsule endoscopy versus
colonoscopy for the detection of polyps and cancer. N Engl J Med.
361:264–270. 2009.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Spada C, Pasha SF, Gross SA, Leighton JA,
Schnoll-Sussman F, Correale L, González Suárez B, Costamagna G and
Hassan C: Accuracy of first- and second-generation colon capsules
in endoscopic detection of colorectal Polyps: A systematic review
and meta-analysis. Clin Gastroenterol Hepatol. 14:1533–1543.e8.
2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Vuik FER, Nieuwenburg SAV, Moen S, Spada
C, Senore C, Hassan C, Pennazio M, Rondonotti E, Pecere S, Kuipers
EJ and Spaander MCW: Colon capsule endoscopy in colorectal cancer
screening: A systematic review. Endoscopy. 53:815–824.
2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Aoki T, Yamada A, Niikura R, Nakada A,
Suzuki N, Hayakawa Y, Hirata Y, Koike K and Fujishiro M: Efficacy
of early video capsule endoscopy for acute overt lower
gastrointestinal bleeding with colonic diverticulosis: A
prospective observational study. Digestion. 103:367–377.
2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Spada C, Hassan C, Galmiche JP, Neuhaus H,
Dumonceau JM, Adler S, Epstein O, Gay G, Pennazio M, Rex DK, et al:
Colon capsule endoscopy: European society of gastrointestinal
endoscopy (ESGE) guideline. Endoscopy. 44:527–536. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Boyapati HPN, Syeda STH, Saravanan A,
Payidiparty D and Anbazhagan PK: Cracking the code of colorectal
cancer screening: An overview with a focus on current and emerging
screening methods. Cureus. 17(e84724)2025.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Puliti D, Sali L, Mascalchi M, Manneschi
G, Intrieri T, Caldarella A, Mallardi B, Masala G, Gorini G, Zappa
M and Mantellini P: Colorectal cancer and advanced adenoma after
single CT colonography or biennial FIT screening in the SAVE
randomized controlled trial. Radiology. 316(e250091)2025.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Hosoe N, Limpias Kamiya KJL, Hayashi Y,
Sujino T, Ogata H and Kanai T: Current status of colon capsule
endoscopy. Dig Endosc. 33:529–537. 2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Eliakim R, Yassin K, Niv Y, Metzger Y,
Lachter J, Gal E, Sapoznikov B, Konikoff F, Leichtmann G, Fireman
Z, et al: Prospective multicenter performance evaluation of the
second-generation colon capsule compared with colonoscopy.
Endoscopy. 41:1026–1031. 2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Gimeno-García AZ, González-Suárez B, Ganzo
ZA, Fernández OA, Ramos L, Giordano A, Carretero C, Jiménez A,
Nicolás D, Guerra MH and Quintero E: Predictive factors for
inadequate bowel cleansing in colon capsule endoscopy.
Gastroenterol Hepatol. 45:605–613. 2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Atkin W, Wooldrage K, Parkin DM,
Kralj-Hans I, MacRae E, Shah U, Duffy S and Cross AJ: Long term
effects of once-only flexible sigmoidoscopy screening after 17
years of follow-up: The UK flexible sigmoidoscopy screening
randomised controlled trial. Lancet. 389:1299–1311. 2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Wang X, Cao L, Song X, Zhu G, Ni B, Ma X
and Li J: Is flexible sigmoidoscopy screening associated with
reducing colorectal cancer incidence and mortality? A meta-analysis
and systematic review. Front Oncol. 13(1288086)2023.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Bretthauer M and Pilonis ND: Brief
sigmoidoscopy provides 21-year colorectal cancer risk reduction in
men. Lancet Gastroenterol Hepatol. 9:777–779. 2024.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Jodal HC, Løberg M, Holme Ø, Adami HO,
Bretthauer M, Emilsson L, Ransohoff DF, Hoff G and Kalager M:
Mortality from postscreening (interval) colorectal cancers is
comparable to that from cancer in unscreened patients-a randomized
sigmoidoscopy trial. Gastroenterology. 155:1787–1794.e3.
2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zhang C, Liu L, Li J, Lv Y, Wu D, Xu S,
Cao C, Zhao L, Liu Y, Ma X, et al: Effect of flexible
sigmoidoscopy-based screening on colorectal cancer incidence and
mortality: An updated systematic review and meta-analysis of
randomized controlled trials. Expert Rev Anticancer Ther.
23:1217–1227. 2023.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Hassan C, Spadaccini M, Iannone A, Maselli
R, Jovani M, Chandrasekar VT, Antonelli G, Yu H, Areia M,
Dinis-Ribeiro M, et al: Performance of artificial intelligence in
colonoscopy for adenoma and polyp detection: A systematic review
and meta-analysis. Gastrointest Endosc. 93:77–85.e6.
2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Guo W and Chen Y: Comments on ‘the impact
of artificial intelligence on the adenoma detection rate:
Comparison between experienced, intermediate and trainee
endoscopists' adenoma detection rate’. Wien Klin Wochenschr.
138:9–10. 2026.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Juul FE, Cross AJ, Schoen RE, Senore C,
Pinsky PF, Miller EA, Segnan N, Wooldrage K, Wieszczy-Szczepanik P,
Armaroli P, et al: Effectiveness of colonoscopy screening vs
sigmoidoscopy screening in colorectal cancer. JAMA Netw Open.
7(e240007)2024.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Rognstad ØB, Botteri E, Hoff G, Bretthauer
M, Gulichsen E, Frigstad SO, Holme Ø and Randel KR: Adverse events
after colonoscopy in a randomised colorectal cancer screening
trial. BMJ OPEN Gastroenterol. 11(e001471)2024.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Imperiale TF, Porter K, Zella J, Gagrat
ZD, Olson MC, Statz S, Garces J, Lavin PT, Aguilar H, Brinberg D,
et al: Next-generation multitarget stool DNA test for colorectal
cancer screening. N Engl J Med. 390:984–993. 2024.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Lin JS, Perdue LA, Henrikson NB, Bean SI
and Blasi PR: Screening for colorectal cancer: Updated evidence
report and systematic review for the US preventive services task
force. JAMA. 325:1978–1998. 2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Jain S, Maque J, Galoosian A, Osuna-Garcia
A and May FP: Optimal strategies for colorectal cancer screening.
Curr Treat Options in Oncol. 23:474–493. 2022.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Zou J, Xiao Z, Wu Y, Yang J and Cui N:
Noninvasive fecal testing for colorectal cancer. Clin Chim Acta.
524:123–131. 2022.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Malik P: A novel multitarget stool DNA
test for colorectal cancer screening. Postgrad Med. 128:268–272.
2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Pantel K and Alix-Panabières C:
Circulating tumour cells in cancer patients: Challenges and
perspectives. Trends Mol Med. 16:398–406. 2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Ren X, Song M, Liu X and He W: Circulating
tumor cells: Mechanisms and clinical significance in colorectal
cancer metastasis. Mol Cancer. 24(242)2025.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Mirza S, Bhadresha K, Mughal MJ, McCabe M,
Shahbazi R, Ruff P and Penny C: Liquid biopsy approaches and
immunotherapy in colorectal cancer for precision medicine: Are we
there yet? Front Oncol. 12(1023565)2023.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Molnár B, Galamb O, Kalmár A, Barták BK,
Nagy ZB, Tóth K, Tulassay Z, Igaz P and Dank M: Circulating
cell-free nucleic acids as biomarkers in colorectal cancer
screening and diagnosis-an update. Expert Rev Mol Diagn.
19:477–498. 2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Urban T, Pokorná P and Slabý O:
Significance of aberrant DNA methylation for cancer diagnostics and
therapy. Klin Onkol. 38:88–94. 2024.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Mostowy S and Cossart P: Septins: The
fourth component of the cytoskeleton. Nat Rev Mol Cell Biol.
13:183–194. 2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Jędrzejczak P, Saramowicz K, Kuś J,
Barczuk J, Rozpędek-Kamińska W, Siwecka N, Galita G, Wiese W and
Majsterek I: SEPT9_i1 and septin dynamics in oncogenesis and cancer
treatment. Biomolecules. 14(1194)2024.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Sun J, Xu J, Sun C, Zheng M, Li Y, Zhu S
and Zhang S: Screening and prognostic value of methylated septin9
and its association with clinicopathological and molecular
characteristics in colorectal cancer. Front Mol Biosci.
8(568818)2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Church TR, Wandell M, Lofton-Day C, Mongin
SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T,
Osborn N, et al: Prospective evaluation of methylated SEPT9 in
plasma for detection of asymptomatic colorectal cancer. Gut.
63:317–325. 2014.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Kim JC and Bodmer WF: Genotypic and
phenotypic characteristics of hereditary colorectal cancer. Ann
Coloproctology. 37:368–381. 2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Song L, Jia J, Peng X, Xiao W and Li Y:
The performance of the SEPT9 gene methylation assay and a
comparison with other CRC screening tests: A meta-analysis. Sci
Rep. 7(3032)2017.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Uraoka T, Hosoe N and Yahagi N:
Colonoscopy: Is it as effective as an advanced diagnostic tool for
colorectal cancer screening? Expert Rev Gastroenterol Hepatol.
9:129–132. 2015.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Leon Arellano M, García-Arranz M,
Guadalajara H, Olivera-Salazar R, Valdes-Sanchez T and García-Olmo
D: Analysis of septin 9 gene hypermethylation as follow-up
biomarker of colorectal cancer patients after curative surgery.
Diagnostics (Basel). 12(993)2022.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Warren JD, Xiong W, Bunker AM, Vaughn CP,
Furtado LV, Roberts WL, Fang JC, Samowitz WS and Heichman KA:
Septin 9 methylated DNA is a sensitive and specific blood test for
colorectal cancer. BMC Med. 9(133)2011.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Sun J, Fei F, Zhang M, Li Y, Zhang X, Zhu
S and Zhang S: The role of mSEPT9 in screening,
diagnosis, and recurrence monitoring of colorectal cancer. BMC
Cancer. 19(450)2019.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Hu J, Hu B, Gui Y, Tan Z and Xu J:
Diagnostic value and clinical significance of methylated SEPT9 for
colorectal cancer: A meta-analysis. Med Sci Monit. 25:5813–5822.
2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Stadler JC, Belloum Y, Deitert B,
Sementsov M, Heidrich I, Gebhardt C, Keller L and Pantel K: Current
and future clinical applications of ctDNA in immuno-oncology.
Cancer Res. 82:349–358. 2022.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Shaukat A, Burke CA, Chan AT, Grady WM,
Gupta S, Katona BW, Ladabaum U, Liang PS, Liu JJ, Putcha G, et al:
Clinical validation of a circulating tumor DNA-based blood test to
screen for colorectal cancer. JAMA. 334:56–63. 2025.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Zhou Q, Chen X, Zeng B, Zhang M, Guo N, Wu
S, Zeng H and Sun F: Circulating tumor DNA as a biomarker of
prognosis prediction in colorectal cancer: A systematic review and
meta-analysis. J Natl Cancer Cent. 5:167–178. 2024.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Lygre KB, Forthun RB, Høysæter T, Hjelle
SM, Eide GE, Gjertsen BT, Pfeffer F and Hovland R: Assessment of
postoperative circulating tumour DNA to predict early recurrence in
patients with stage I-III right-sided colon cancer: Prospective
observational study. BJS Open. 8(zrad146)2024.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Cassinotti E, Melson J, Liggett T,
Melnikov A, Yi Q, Replogle C, Mobarhan S, Boni L, Segato S and
Levenson V: DNA methylation patterns in blood of patients with
colorectal cancer and adenomatous colorectal polyps. Int J Cancer.
131:1153–1157. 2012.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Chen Y, Wang Z, Zhao G, Sun C, Ma Y, Zhang
L, Zheng M and Li H: Performance of a novel blood-based early
colorectal cancer screening assay in remaining serum after the
blood biochemical test. Dis Markers. 2019(5232780)2019.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Zhao G, Li H, Yang Z, Wang Z, Xu M, Xiong
S, Li S, Wu X, Liu X, Wang Z, et al: Multiplex methylated DNA
testing in plasma with high sensitivity and specificity for
colorectal cancer screening. Cancer Med. 8:5619–5628.
2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Bessa X, Vidal J, Balboa JC, Márquez C,
Duenwald S, He Y, Raymond V, Faull I, Burón A, Álvarez-Urturi C, et
al: High accuracy of a blood ctDNA-based multimodal test to detect
colorectal cancer. Ann Oncol. 34:1187–1193. 2023.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Lu L, Bi J and Bao L: Genetic profiling of
cancer with circulating tumor DNA analysis. J Genet Genomics.
45:79–85. 2018.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Bork U, Rahbari NN, Schölch S, Reissfelder
C, Kahlert C, Büchler MW, Weitz J and Koch M: Circulating tumour
cells and outcome in non-metastatic colorectal cancer: A
prospective study. Br J Cancer. 112:1306–1313. 2015.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Edge SB and Compton CC: The american joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.
2010.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Baek DH, Kim GH, Song GA, Han IS, Park EY,
Kim HS, Jo HJ, Ko SH, Park DY and Cho YK: Clinical potential of
circulating tumor cells in colorectal cancer: A prospective study.
Clin Transl Gastroenterol. 10(e00055)2019.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Tsai WS, You JF, Hung HY, Hsieh PS, Hsieh
B, Lenz HJ, Idos G, Friedland S, Yi-Jiun Pan J, Shao HJ, et al:
Novel circulating tumor cell assay for detection of colorectal
adenomas and cancer. Clin Transl Gastroenterol.
10(e00088)2019.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Lu G, Lu Z, Li C, Huang X and Luo Q:
Prognostic and therapeutic significance of circulating tumor cell
phenotype detection based on epithelial-mesenchymal transition
markers in early and midstage colorectal cancer first-line
chemotherapy. Comput Math Methods Med. 2021(2294562)2021.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Li M, Li L, Zheng J, Li Z, Li S, Wang K
and Chen X: Liquid biopsy at the frontier in renal cell carcinoma:
Recent analysis of techniques and clinical application. Mol Cancer.
22(37)2023.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Chen F, Wang S, Fang Y, Zheng L, Zhi X,
Cheng B, Chen Y, Zhang C, Shi D, Song H, et al: Feasibility of a
novel one-stop ISET device to capture CTCs and its clinical
application. Oncotarget. 8:3029–3041. 2017.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Chen AQ, Gao XF, Wang ZM, Wang F, Luo S,
Gu Y, Zhang JJ and Chen SL: Therapeutic exosomes in prognosis and
developments of coronary artery disease. Front Cardiovasc Med.
8(691548)2021.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Akter A, Kamal T, Akter S, Auwal A and
Islam F: Exosomes: A potential tool in the diagnosis, prognosis and
treatment of patients with colorectal cancer. Future Oncol.
21:2347–2365. 2025.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Gamez J, Zha D, Ebrahimi SM, White S,
Ljubimov AV and Saghizadeh M: Exosomes as future therapeutic tools
and targets for corneal diseases. Cells. 14(959)2025.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Nam GH, Choi Y, Kim GB, Kim S, Kim SA and
Kim IS: Emerging prospects of exosomes for cancer treatment: From
conventional therapy to immunotherapy. Adv Mater.
32(2002440)2020.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Liu T, Liu D, Guan S and Dong M:
Diagnostic role of circulating MiR-21 in colorectal cancer: A
update meta-analysis. Ann Med. 53:87–102. 2021.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Lin J, Chuang CC and Zuo L: Potential
roles of microRNAs and ROS in colorectal cancer: Diagnostic
biomarkers and therapeutic targets. Oncotarget. 8:17328–17346.
2017.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Jin XH, Lu S and Wang AF: Expression and
clinical significance of miR-4516 and miR-21-5p in serum of
patients with colorectal cancer. BMC Cancer. 20(241)2020.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Liu B, Su F, Chen M, Li Y, Qi X, Xiao J,
Li X, Liu X, Liang W, Zhang Y and Zhang J: Serum miR-21 and
miR-125b as markers predicting neoadjuvant chemotherapy response
and prognosis in stage II/III breast cancer. Hum Pathol. 64:44–52.
2017.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Ng L, Wan TMH, Man JHW, Chow AKM, Iyer D,
Chen G, Yau TCC, Lo OSH, Foo DCC, Poon JTC, et al: Identification
of serum miR-139-3p as a non-invasive biomarker for colorectal
cancer. Oncotarget. 8:27393–27400. 2017.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Cheng X, Zhao W, Ren D, Xia X, Lu S, Chen
D, Wang X, Li Q, Lu Q, Gu Y, et al: RNA transcription assisted
universal CRISPR/Cas12a system for programmable analysis of
multiple colorectal cancer-associated microRNAs. Talanta.
282(126960)2025.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Gude SS, Veeravalli RS, Vejandla B, Gude
SS, Venigalla T and Chintagumpala V: Colorectal cancer diagnostic
methods: The present and future. Cureus. 15(e37622)2023.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Zhang Z, Liu X, Peng C, Du R, Hong X, Xu
J, Chen J, Li X, Tang Y, Li Y, et al: Machine learning-aided
identification of fecal extracellular vesicle microRNA signatures
for noninvasive detection of colorectal cancer. ACS Nano.
19:10013–10025. 2025.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Higuchi K, Kaise M, Noda H, Kirita K,
Koizumi E, Umeda T, Akimoto T, Omori J, Akimoto N, Goto O, et al:
Three-dimensional flexible endoscopy enables more accurate
endoscopic recognition and endoscopic submucosal dissection marking
for superficial gastric neoplasia: A pilot study to compare two-
and three-dimensional imaging. Surg Endosc. 35:6244–6250.
2021.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Sun X, Zhang Q, Wu S, Xu C, Zhang Y, Hao
X, Meng Y, Jiao Y, Li H, Zhu S, et al: Effect of 3-dimensional
imaging device on polyp and adenoma detection during colonoscopy: A
randomized controlled trial. Am J Gastroenterol. 118:1812–1820.
2023.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Tang D, Zhou J, Wang L, Ni M, Chen M,
Hassan S, Luo R, Chen X, He X, Zhang L, et al: A novel model based
on deep convolutional neural network improves diagnostic accuracy
of intramucosal gastric cancer (with video). Front Oncol.
11(622827)2021.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Muhammad F Dawwas: Adenoma detection rate
and risk of colorectal cancer and death. N Engl J Med.
370:2539–2540. 2014.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Xie J, Dong X, Luo Z, Wang C, Zheng Y,
Chen X, Guo Z, Shi X, Wang F, Cao W, et al: The impact of adherence
on colorectal cancer screening cost-effectiveness: A modeling
study. PLoS Med. 22(e1004807)2025.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Lu B, Luo J, Yan Y, Zhang Y, Luo C, Li N,
Zhou Y, Wu D, Dai M and Chen H: Evaluation of long-term benefits
and cost-effectiveness of nation-wide colorectal cancer screening
strategies in China in 2020-2060: A modelling analysis. Lancet Reg
Health West Pac. 51(101172)2024.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Huang J, Chan VCW, Chen M, Liew JJM, Liu
X, Zhong C, Lin J, Hang J, Zhong CC, Yuan J, et al: Revisiting the
starting age of colorectal cancer screening for the average-risk
Asian population: A cost-effectiveness analysis. Gastrointest
Endosc. 102:717–725.e2. 2025.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Kastrinos F, Kupfer SS and Gupta S:
Colorectal cancer risk assessment and precision approaches to
screening: Brave new world or worlds apart? Gastroenterology.
164:812–827. 2023.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY,
Wu DC, Matsuda T, Byeon JS, Lee SK, Goh KL, et al: The Asia-Pacific
colorectal Screening score: A validated tool that stratifies risk
for colorectal advanced neoplasia in asymptomatic Asian subjects.
Gut. 60:1236–1241. 2011.PubMed/NCBI View Article : Google Scholar
|
